@article{TAU17975,
author = {Jan F. M. Verbeek and Monique J. Roobol and the ERSPC Rotterdam study group},
title = {What is an acceptable false negative rate in the detection of prostate cancer?},
journal = {Translational Andrology and Urology},
volume = {7},
number = {1},
year = {2018},
keywords = {},
abstract = {Background: In prostate cancer (PCa) screening men and their physicians aim to rule out the presence of potentially life threatening PCa. To date, prostate specific antigen (PSA) testing and systematic prostate biopsy (Bx)—in case of an elevated PSA—are still the main modes of PCa detection. Often uncertainty remains when a PSA-test is },
issn = {2223-4691}, url = {https://tau.amegroups.org/article/view/17975}
}